Menu

frank fager

3363 posts

Posts (3363)

frank fager IBRX 3 minutes ago #1

The only way IBRX really takes off it if the MSM corrupt media gives it fair coverage. With fair coverage IBRX is a $25-$50 stock in weeks

frank fager IBRX 5 minutes ago #2

Kato rooba

They are quiet for a reason to avoid litigation from the ass raping class action predictors and I think it's a quiet period proceeding a huge announcement such as buy out or partnership or partial sale.

frank fager IBRX 59 minutes ago #3

It's like they are in a quiet period leading up to the big news release.

They have always done investor calls in the past why not now? Seems suspicious

frank fager IBRX 1 hour ago #4

My theory is something huge is coming, like a partnership or partial or full sale of the company

frank fager IBRX 1 hour ago #6

No cons takes time to build sales and steal market share and get Drs providers to switch their protocols. Doesn't happen over night takes months even years to convince them to change. Many get in a rut doing the same thing over and over and don't even know about a new treatment. People think all Drs keep up new break through they don't... Take time

frank fager IBRX 1 hour ago #7

If ImmunityBio IBRX is a spec why did it sell off on sales and earnings? It's a real company now. Now we need the idiot Wall Street analysts to be more accurate

frank fager IBRX 14 hours ago #8

1 billion shares times what equals a trillion

1000 there are many trillion and multi trillion dollar company so let's think retard small.

1 billion time say $25 is wow 25 billion

Do you know Merck's Keytruda sales are 30 billion a year.

THERE ARE SO MANY 2 DIGIT IQ IDIOTS IN THE COUNTRY AND SEEMS MANY POST ON THIS BOARD DAILY

frank fager IBRX 22 hours ago #9

Maybe no investor call yet because something huge is in the final negotiations and and and boom 🚀

Big corrupt Pharma could buy IBRX out for say 25 billion and in 2-4 years be selling 25-50 billion a year. That about $25/share

Pay $25 a share and take it over keep the company together and Dr PSS on and boom sales would explode and FDA will do as told... Merck is the most likely because Keytruda's patent ends end of 2028

Let's hope $25/ share plus works for me and I am done will buy etf and forget about it with a New York accent

frank fager IBRX 22 hours ago #10

Maybe no investor call yet because something huge is in the final negotiations and and and boom 🚀